The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's nasal spray flu vaccine for ...

In a report released today, Eric Le Berrigaud from Stifel Nicolaus maintained a Buy rating on AstraZeneca (AZN – Research Report), with a ...

AstraZeneca PLC (AZN, AZN.L) announced Wednesday that its Fasenra (benralizumab) has been approved in the US for the treatment of ...

Sanofi said on Monday the U.S. Food and Drug Administration has approved a manufacturing line for its and partner AstraZeneca ...

FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider, the ...

Shares of AstraZeneca PLC AZN inched up 0.35% to £118.98 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE 100 Index UKX rising 0.91% to 8,328.

Meet the Management at ESMO 2024 Conference September 16, 2024 2:00 PM ETCompany ParticipantsPascal Soriot - Chief ...

The FDA previously rejected patritumab deruxtecan over manufacturing issues. Tuesday's study data should boost the companies' case, however.

Research highlights the use of multimodal machine learning to identify non-small cell lung cancer patients predicted to ...

"System errors" meant a man who died after being given the AstraZeneca Covid-19 vaccine was wrongly invited to have the jab, an independent report has found. Jack Last, 27, an engineer from ...

A probe into failings linked to the death of Jack Last, a young man who died in April 2021 from a blood clot linked to the Oxford-AstraZeneca jab, revealed the 27-year-old was wrongly called up ...